Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols Helene FilbertSebastian AttigCedrik M. Britten Original Article Open access 09 November 2012 Pages: 615 - 627
Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas Muhammad BaghdadiHiroko NagaoMasahisa Jinushi Original article 10 November 2012 Pages: 629 - 637
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy Daisuke NobuokaToshiaki YoshikawaTetsuya Nakatsura Original article Open access 11 November 2012 Pages: 639 - 652
TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis Zhijuan DiaoJuan ShiDexian Zheng Original article 11 November 2012 Pages: 653 - 663
Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40 + CpG Kory L. AldersonMitchell LuangrathPaul M. Sondel Original article 15 November 2012 Pages: 665 - 675
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells Tomoharu SugieKaoru Murata-HiraiYoshimasa Tanaka Original article 15 November 2012 Pages: 677 - 687
Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it Zhu XishanZhou XinnaRen Jun Original article 21 November 2012 Pages: 689 - 703
Properties of monocytes generated from haematopoietic CD34+ stem cells from bone marrow of colon cancer patients Malgorzata StecJarosław BaranMarek Zembala Original article Open access 24 November 2012 Pages: 705 - 713
Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides Stefanie Andrea Erika HeldKatharina Maria DuchardtAnnkristin Heine Original article 25 November 2012 Pages: 715 - 726
Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails Shicheng YangYun JiRichard A. Morgan Original article 04 December 2012 Pages: 727 - 736
Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma Roniel CabreraMiguel AraratDavid R. Nelson Original Article 07 December 2012 Pages: 737 - 746
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses Stéphanie CorgnacRachel PerretAlena Donda Original article Open access 15 December 2012 Pages: 747 - 760
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses Claudia Durán-AniotzGabriela SegalMercedes N. López Original article 15 December 2012 Pages: 761 - 772
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors Emmet McCormackKatherine J. AdamsBent K. Jakobsen Original article Open access 22 December 2012 Pages: 773 - 785
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses Hyun-Il ChoKelly BarriosEsteban Celis Original Article 25 December 2012 Pages: 787 - 799
Functional human Th17 clones with WT1-specific helper activity Sho TachinoFumihiro FujikiHaruo Sugiyama Original article 29 December 2012 Pages: 801 - 810
Inhibition of both BRAF and MEK in BRAFV600E mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties Patrick A. OttTrevor HenryNina Bhardwaj Original article 10 January 2013 Pages: 811 - 822
